DeNovo Ventures is a venture capital firm based in Saratoga, California and founded in 2000.
With $650 million under management, DeNovo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth - from early stage to late stage. They work to advise entrepreneurs and management teams over the full life cycle of their portfolio company.
DeNovo Ventures has raised a total of $650 million across three funds. They announced their De Novo Ventures I on January 2000, with a raised total of $100 million. In January 2004, they announced their De Novo Ventures II with a raised total of $250 million. And in January 2006, the announced their De Novo Ventures III with a raised total of $300 million.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Avedro is a company that is advancing the field of Corneal Remodeling.
TRIA Beauty is a San Leandro, California-based company founded by Tobin Island.
A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
A medical device company developing treatments for pains and aesthetics
A company developing medical devices and technologies to diagnose and treat pulmonary disorders
A company that develops implantable devices for the treatment of cardiac arrhythmias
A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders
A company developing and providing microcatheter and imaging technologies for ocular therapies
A company developing and providing measurement technology surgeons of cataract patients
Richard M. Ferrari